The Canada enteral nutrition market size is expected to grow from CA$ 514.33 million in 2023 to CA$ 817.11 million by 2031; the market is estimated to register a CAGR of 6.0% from 2023 to 2031.
Enteral nutrition refers to any method of feeding that involves the gastrointestinal (GI) tract to deliver nutrition for fulfilling an individual’s caloric requirements. It can include a normal oral diet, liquid supplements, or delivery using a tube (tube feeding). Enteral nutrition is necessary for patients whose energy and nutritional needs cannot be met by a regular food intake. The Canada enteral nutrition market report emphasizes the key factors driving the market and depicts the developments of prominent players.
Key factors bolstering the Canada enteral nutrition market include a surge in the prevalence of cachexia and related disorders and a rise in the prevalence of gastrointestinal diseases. Further, the specific formulations and plant-based nutrition products are expected to bring new Canada enteral nutrition market trends in the coming years.
Growth Drivers and Restraints:
The Canadian Mental Health Association celebrates Eating Disorder Awareness Week by wearing purple on February 1, Every year. Cachexia, anorexia, and eating disorders are related in a way that highlights the complex interactions between physiological, psychological, and metabolic aspects. Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. In people with underlying medical disorders, anorexia (a chronic lack of appetite or reduced food intake) may play a role in the onset or aggravation of cachexia. Reduced calorie intake in anorexic patients further hampers their metabolic capacity to preserve muscle mass, store vital nutrients, and attain general metabolic equilibrium, subsequently accelerating the development of cachexia. According to the National Initiative for Eating Disorders, as of 2023, anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), avoidance restrictive food intake disorder (ARFID), and otherwise specified feeding and eating disorder (OSFED) affect approximately 1 million Canadians who have been diagnosed with an eating disorder. Additionally, according to the Canadian Community Health Survey, 1.8% of women aged 65 or more and 2.6% of women from the age group of 50–64 reported having an eating disorder. Thus, with the burgeoning incidence of cachexia, anorexia, and eating disorders—collaborative efforts, awareness initiatives, and implementation of tailored interventions that target both the physical and psychological aspects of the abovementioned conditions support the Canada enteral nutrition market growth.
For many years, the enteral nutrition method has been in use to feed patients who are unable or unwilling to consume food in quantities sufficient for their daily needs. However, the method may lead to various complications due to the techniques applied. When a wide bore tube is used for feeding, the size and rigidity of the tube tend to produce inflammation and irritation. The tube can also encourage gastroesophageal reflux. Fine-bore tubes are prone to coil up in the oropharynx region or to wander off course into the trachea during the insertion process, particularly since the patients are unconscious during the insertion process. Owing to the risk of misplacement, it is important to ensure the correct positioning of a tube before feeding, as it may adversely affect the aspiration in the stomach if not placed properly. These are the mechanical or tube-related aspects that limit the adoption of enteral nutrition methods.
Further, enteral feeding may be followed by nausea, vomiting, diarrhea, constipation, and many gastrointestinal complications. According to Clinical Nutrition Espen, 20% of the total patients on enteral nutrition suffer from nausea, vomiting, bloating, and abdominal cramps. Diarrhea is the most common gastrointestinal complication caused by enteral nutrition, occurring within a wide range of 2–63%. Dehydration, hyperglycemia, electrolyte abnormalities, vitamin and trace element deficiencies, liver function abnormalities, and other metabolic abnormalities may arise during enteral feeding due to the imprudent choice of feed and lack of adequate monitoring. Thus, mechanical complications, gastrointestinal complications, metabolic complications, etc., hinder the Canada enteral nutrition market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Canada Enteral Nutrition Market: Strategic Insights
Canada Enteral Nutrition Market
-
CAGR (2023 - 2031)
6.0%
-
Market Size 2023
CA$ 514.33 Million
-
Market Size 2031
CA$ 817.11 Million
Market Dynamics
GROWTH DRIVERS
- Surge in Prevalence of Cachexia and Related Disorders
- Rise in Prevalence of Gastrointestinal Diseases
FUTURE TRENDS
- Specific Formulations and Plant-Based Nutrition Products
OPPORTUNITIES
- Use of Next-Generation Technologies to Ensure Proper Feeding Routines
Key Players
- Nestle SA,
- Abbott Laboratories,
- Fresenius Medical Care AG & Co KGaA,
- Koninklijke DSM NV,
- B Braun SE,
- Others
Regional Overview
- Canada
Market Segmentation
Disease Indication
- Orthopedic Disorders
- cardiovascular Disorders
- Oncology
- Neurological Disorders
- Others
Formula Type
- Standard Formulas
- Peptide Formulas
- Specialized Formulas
Route Of Administration
- Oral
- Tube Feed
End User
- Long Term Care Facilities
- Hospitals
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Canada Enteral Nutrition Market: Strategic Insights
-
CAGR (2023 - 2031)6.0% -
Market Size 2023
CA$ 514.33 Million -
Market Size 2031
CA$ 817.11 Million
Market Dynamics
- Surge in Prevalence of Cachexia and Related Disorders
- Rise in Prevalence of Gastrointestinal Diseases
- Specific Formulations and Plant-Based Nutrition Products
- Use of Next-Generation Technologies to Ensure Proper Feeding Routines
Key Players
- Nestle SA,
- Abbott Laboratories,
- Fresenius Medical Care AG & Co KGaA,
- Koninklijke DSM NV,
- B Braun SE,
- Others
Regional Overview
- Canada
Market Segmentation
Disease Indication - Orthopedic Disorders
- cardiovascular Disorders
- Oncology
- Neurological Disorders
- Others
Formula Type - Standard Formulas
- Peptide Formulas
- Specialized Formulas
Route Of Administration - Oral
- Tube Feed
End User - Long Term Care Facilities
- Hospitals
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Segmentation and Scope:
The Canada enteral nutrition market analysis has been carried out by considering the following segments: disease indication, formula type, route of administration, and end user. Based on disease indication, the market is differentiated into Orthopedic Disorders, Cardiovascular Disorders, Oncology, Neurological Disorders, and Others. By route of administration, the Canada enteral nutrition market is segmented into oral and tube feed. In terms of formula type, the market is differentiated into standard formulas (whole protein formulas), peptide formulas (semi-elemental formulas), and specialized formulas. On the basis of end users, the Canada enteral nutrition market is classified into hospitals, long-term care facilities, and others.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
Based on disease indication, the orthopedic disorders segment held the largest Canada enteral nutrition market share in 2023. The cardiovascular disorders segment is anticipated to register the highest CAGR during 2023–2031.
Canada Enteral Nutrition Market, by Disease Indication – 2023 and 2031
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Based on formula type, the companion animals segment held a larger market share in 2023. The standard formulas segment held the largest Canada enteral nutrition market share; it is anticipated to register the highest CAGR from 2023 to 2031. Based on the route of administration, the oral segment held a larger share of the Canada enteral nutrition market in 2023, and the same segment is anticipated to register a higher CAGR during 2023–2031. In terms of end user, the long-term care facilities segment is anticipated to account for a significant market share during 2023–2031.
Country Overview:
The Canadian Cancer Statistics Advisory Committee estimated ~225,800 new cancer cases and 83,300 deaths due to cancer in Canada in 2020. According to Canadian Cancer Society estimates, 2 in 5 Canadians are diagnosed with cancer in their lifetime. Per the same source, ~229,200 people in the country were diagnosed with cancer and 84,600 died from it in 2021. The Canadian Digestive Health Foundation states that millions of Canadians live with digestive disease. ~20 million Canadians, i.e., 2 of every 3 people, suffer from digestive disorders yearly. Parenteral and enteral nutrition helps administer vital nutrients, which helps maintain strength, energy, and hydration levels in patients suffering from cancer (all stages). The increasing prevalence of chronic conditions, such as cancer and gastrointestinal disorders, propel the demand for enteral and parenteral nutrition products in Canada. Enteral nutrition is also a preferred method of nutritional support when the gastrointestinal tract is functional, but the patient is unable to have an adequate oral intake of nutrients to fulfill nutritional requirements.
The Canadian government and private organizations are taking several initiatives to boost the enteral nutrition practice. For instance, the Canadian Cancer Society is creating awareness about enteral nutrition and tube feeding among cancer patients. Further, the BC Home Enteral Nutrition (HEN) Program, in collaboration with Oley Foundation, supports patients with specialized nutrition needs from British Columbia and the Yukon. It creates awareness and helps patients live enhanced life through advocacy, education, and networking. The Canada enteral nutrition market forecast can help stakeholders in this marketplace plan their growth strategies.
Competitive Landscape and Key Companies:
Nestle SA, Abbott Laboratories, Fresenius Medical Care AG & Co KgaA, Koninklijke DSM NV, and B Barun SE are among the prominent players profiled in the Canada enteral nutrition market report. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the burgeoning consumer demand and expand their product range in specialty portfolios.
Canada Enteral Nutrition Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | CA$ 514.33 Million |
| Market Size by 2031 | CA$ 817.11 Million |
| Global CAGR (2023 - 2031) | 6.0% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Disease Indication
|
| Regions and Countries Covered |
Canada
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Frequently Asked Questions
Key factors driving the Canada enteral nutrition market growth include the surge in prevalence of cachexia and related disorders and rise in prevalence of gastrointestinal diseases.
The Canada enteral nutrition market analysis has been carried out by considering the following segments: disease indication, formula type, route of administration, and end user. Based on disease indication, the market is differentiated into orthopedic disorders, cardiovascular disorders, oncology, neurological disorders, and others. By route of administration, the Canada enteral nutrition market is segmented into oral and tube feed. In terms of formula type, the market is differentiated into standard formulas (whole protein formulas), peptide formulas (semi-elemental formulas), and specialized formulas. On the basis of end user, the Canada enteral nutrition market is classified into hospitals, long-term care facilities, and others.
The Canada Enteral Nutrition Market majorly consists of the players such Nestle SA, Abbott Laboratories, Fresenius Medical Care AG & Co KgaA, Koninklijke DSM NV, and B Barun SE.
Enteral nutrition refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver nutrition and calories to fulfill an individual’s caloric requirements. It can include a normal oral diet, liquid supplements, or delivery using a tube (tube feeding). It is provided to patients whose energy and nutritional needs cannot be met by a regular food intake. The Canada enteral nutrition market report emphasizes the key factors driving the market and depicts the developments of prominent players.
The List of Companies - Canada Enteral Nutrition Market
- Nestle SA
- Abbott Laboratories
- Fresenius Medical Care AG & Co KgaA
- Koninklijke DSM NV
- B Barun SE
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Canada Enteral Nutrition Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)